
Plastic surgery trends take a surprising turn, as doctors see more patients 'sizing down'
These days, bigger isn't always better when it comes to cosmetic surgery.
The so-called "Kardashian" look, which once popularized Brazilian butt lifts, breast augmentations and lip filler, is no longer the hot trend, some experts say.
Plastic surgeons agree that they're seeing more patients sizing down their appearance, opting for breast reductions and dissolving facial fillers.
Board-certified plastic surgeon Dr. Stafford Broumand, of 740 Park Plastic Surgery in New York, confirmed that his patients are looking for "more natural results versus overdone."
"Patients are looking for more natural and petite curves, smaller breast implants, and fat grafting to round out the buttock, not necessary to enlarge the buttock," he shared with Fox News Digital. "Patients want symmetry in their body and face, and soft, full lips – a youthful appearance."
The surgeon added that younger patients have been inquiring about facelifts more often, and more patients are looking for natural contours and removal of excess skin.
"The 'overdone' or fake appearance has fallen out of favor."
Dr. Babak Azizzadeh, Beverly Hills plastic surgeon and co-founder of Persana — an online concierge that connects people with aesthetic physicians — said the biggest trend he's seeing is people dissolving fillers.
"We are seeing this with fillers that were injected in the wrong place or with too much product," he told Fox News Digital.
"Unlike Botox, which breaks down in three to four months, we have learned from recent literature and studies that fillers last much longer, potentially years, when patients had previously been coming in for more filler every six to 12 months."
Azizzadeh added that patients are looking for a more "conservative aesthetic."
"While patients are still utilizing fillers — and when done correctly, they can be fantastic — we are seeing patients requesting more fat grafting and surgical lip lifts to achieve their natural aesthetic goals," he noted.
Dr. Lyle Leipziger, chief of plastic surgery at North Shore University Hospital and LIJ Medical Center in New York, shared that in his practice, patients are seeking a more "athletic, physically fit appearance."
Leipziger also confirmed that there has been a "significant increase" in breast reductions and breast lifts with or without small implants.
"Patients are now seeking facelifts, breast lifts and body contouring procedures in much greater numbers," he said.
The growing popularity of weight-loss medicatiobfns like Ozempic for treating diabetes and obesity has "tremendously" impacted plastic surgery trends, according to Azizzadeh.
When people experience significant weight loss, it changes the volume in the face, creating more laxity, the surgeon said.
"Second, it impacts fat cells directly. As a result, we are seeing more facelifts, neck lifts, fat grafting, and we are also seeing this in younger patients than previously."
Broumand agreed that the trend of semaglutides (the active ingredient in many weight-loss medications) has impacted the plastic surgery process.
"Patients who want to follow a specific body trend may have regrets later, once that becomes outdated."
"Before Ozempic, we would be removing fat and contouring a patient's shape," he told Fox News Digital. "With the weight-loss drugs, we still have to contour, but we might need to add volume and remove extra skin."
Leipziger agreed that Ozempic and other semaglutides have "significantly fueled plastic surgery procedures as well as injectables."
"People who undergo rapid weight loss are often happy when they get on the scale and buy smaller clothes," he said. "However … they may discover their face and body appear to be aging and sagging prematurely."
This has led to an increase in facelift requests and body contouring procedures, according to the doctor.
"It is very important to discuss with any patient who comes in after their weight loss whether they'll be able to maintain their new weight before performing face or body contouring procedures," he advised, noting that this is especially important for those who have lost weight quickly.
Social media has called attention to potential complications of plastic surgery, such as the phenomenon of "pillow face," which can occur when the face is appears puffy after too much filler.
For more Health articles, visit www.foxnews.com/health
"I think a lot of patients have learned that going to reputable, board-certified plastic surgeons and qualified injectors makes a huge difference in outcomes," Broumand commented.
The plastic surgeon added that he's "always been a believer" in doing what's right for his patients instead of following the trends.
"Trends should be for clothing," he said. "Patients who want to follow a specific body trend may have regrets later, once that becomes outdated and they don't have the ability to reverse the surgery."
Azizzadeh also encouraged future plastic surgery recipients to prioritize picking the right doctor, as the same procedure can have "widely varying results" depending on the physician's ability, experience, skills and "artistic view."
"Overall, the trend with all procedures is natural-looking results," the surgeon said. "The 'overdone' or fake appearance has fallen out of favor, with celebrities and influencers championing the no-makeup, clean-face look."
"While people are getting more plastic surgery now than ever, the focus has shifted toward subtle enhancements that look effortless and natural."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
UFC Fighter Ariane da Silva's Brain Tumor Made Weight Cut Impossible, Now Promotion May Cut Her After Third Consecutive Loss
UFC Fighter Ariane da Silva's Brain Tumor Made Weight Cut Impossible, Now Promotion May Cut Her After Third Consecutive Loss originally appeared on Athlon Sports. UFC fighters routinely push their bodies to dangerous extremes just to step on the scale—starving for weeks, sweating out water in saunas until they faint, and enduring kidney-straining dehydration protocols. The sport's weight-cutting culture forces athletes to gamble with their health, often walking the line between competition and hospitalization in pursuit of a size advantage. Advertisement These practices persist despite medical emergencies. Behind every weigh-in, there's often an untold story of suffering that does not get the spotlight as much as the knockout finishes and the trash talk. Dana WhiteGetty Images UFC flyweight Ariane da Silva's shocking six-pound weight miss ahead of her UFC 316 bout against Wang Cong was caused by complications from a benign pituitary tumor, her coach and husband Renato da Silva revealed during an interview with MMA Fighting. The Brazilian fighter, who tipped the scales at 132 pounds—well above the 126-pound non-title limit—underwent a dangerous weight cut attempt while managing hormonal imbalances triggered by the tumor. Advertisement Blood tests during her camp showed elevated prolactin and cortisol levels, leading to the discovery of the tumor, which disrupted her body's ability to shed weight safely. The situation worsened when da Silva's team enlisted a new nutritionist, whose strategy to retain water until the final days of the weight cut, backfired catastrophically. Renato described harrowing symptoms during the final push, including double vision, slurred speech, and loss of motor control—clear signs her body was shutting down. He emphasized that UFC medical staff intervened to halt the cut after deeming it life-threatening, saying, 'She wasn't walking right, blinking too slow, and couldn't focus.' Advertisement Her coach's decision to allow her to continue to fight despite these issues was baffling and was met with criticism by some people online. SportingNews journalist Val Dewar shared the interview on X (formerly Twitter), and expressed his opinion that 'Fighting with a tumor in your f— brain, even a benign one, seems like a bad Idea. Like, [a] really, really bad idea.' Her opponent Wang Cong was gracious enough to agree to a catchweight bout despite the weight disparity and accepted 30% of da Silva's purse. Wang also expressed sympathy on social media towards da Silva and her struggle trying to make weight, saying, 'After she came out, I went over to see her situation. Fortunately, there is no big problem, because it's not easy for every athlete.' Advertisement Da Silva ultimately lost a unanimous decision to Cong, extending her skid to three fights and putting her in the crosshairs of being cut from the promotion. The incident casts a spotlight on MMA's weight-cutting crisis, where fighters often gamble with extreme measures to hit weight targets before a fight. Da Silva's case is uniquely alarming due to the tumor's role, raising questions about whether she should have been cleared to fight at all. The UFC has yet to address if da Silva will receive medical suspension or specialized support moving forward. Related: UFC Champion Alexander Volkanovski Suffers Medical Scare During Fight 'I could not see' Related: UFC Coach Reveals He Nearly Pulled Out 'Half-Dead' Champion from Title Defense Due to Severe Medical Issues This story was originally reported by Athlon Sports on Jun 8, 2025, where it first appeared.
Yahoo
10 hours ago
- Yahoo
'RHONJ''s Dolores Catania Says She Gained 20 Lbs. After Mounjaro ‘Stopped Working': ‘I'm Having a Really Hard Time'
Dolores Catania revealed she gained 20 lbs. after her Mounjaro 'stopped working' The RHONJ star she's 'having a really hard time' dealing with the weight gain She admitted that there's a possibility her weight gain could be due to the slew of heart medications she's been takingDolores Catania is struggling with weight gain even while taking Mounjaro. On June 6, the Real Housewives of New Jersey star, 54, appeared on SiriusXM's Jeff Lewis Live and talked about taking Mounjaro, an FDA-approved prescription medication for people with type 2 diabetes. It's a brand name for tirzepatide, which is highly effective for weight loss by reducing appetite and improving how the body breaks down sugar and fat. Mounjaro is similar to Ozempic and Wegovy — brand names for semaglutide. They work in the brain to impact satiety and have been trending in and out of Hollywood. Catania — who previously shared that she lost 20 lbs. with the medication — revealed on the show that she's now gained the weight back. 'I'm having a really hard time right now. My Mounjaro stopped working, I gained 20 lbs.,' she shared. 'I've been looking for therapy for all my friends. I'm really having a bad time with this.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Lewis asked if she's able to switch to another medication like Ozempic and she immediately replied, 'I did it all.' Catania said she has since stopped taking the medication for about a month because she needed to undergo a cardiac ablation — a minimally invasive procedure where doctors freeze or burn the inside of the heart to restore a normal heart rhythm. The Bravo star assured that she's 'fine' now and was only in the hospital for the procedure. 'I'm on a bunch of medicine, like, 10 pills a day,' she said. 'It's just a formality now. I have to take it for the next 90 days, then I should be done.' 'Maybe that's why I gained weight,' she said of all the new medications. 'I'm hoping maybe that's why.' ! is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! Catania previously spoke about her success on Mounjaro in 2023. "I'm down 20 pounds," she told The U.S. Sun, adding that her goal weight "is to be in the low 130s." The reality star admitted that she was previously 'gaining weight every month' and got up to 163 lbs. before trying the medication and seeing some results. 'It doesn't happen overnight. It doesn't come off easy," she said. Catania was originally prescribed Ozempic, taking the drug for two years before switching to Mounjaro in early 2023. 'I was medically prescribed for both because I am insulin resistant/pre-diabetic and have a thyroid issue,' she said at the time. Catania stressed that although she was still hoping to lose more weight on Mounjaro, taking these medications isn't a quick fix to weight loss, insisting that she focuses on exercising, healthy eating, and limiting her drinking — minus the wild nights spent with her RHONJ castmates. "I stopped taking [Ozempic] because it was expensive and everything. But being healthy and living a healthy lifestyle is cheap — it's free!" she told the outlet. "I work out regularly. There is no easy fix for weight loss and I have to watch what I eat." Read the original article on People


UPI
11 hours ago
- UPI
CPAP or Zepbound? Patients, doctors debate sleep apnea treatment
Doctors favor treatment with continuous positive airway pressure, or CPAP, machines, researchers are slated to report this week at a meeting of the American Academy of Sleep Medicine. Adobe stock June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive airway pressure, or CPAP, machines, researchers are slated to report this week at a meeting of the American Academy of Sleep Medicine. The machines keep airways open using mild air pressure provided through a mask patients wear while sleeping. But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness data of CPAP versus tirzepatide, and a potential mismatch between patient and provider preferences when managing comorbid obesity and obstructive sleep apnea," lead researcher Ahmed Khalaf said in a news release. He's a sleep technician in the pulmonary, critical care and sleep medicine division at University of California-San Diego. Nearly 30 million adults in the United States have sleep apnea, a disease in which the upper airway collapses during sleep, causing people to wake repeatedly. CPAP has been considered the gold standard for treating sleep apnea, but some patients find the machines too bulky and noisy. About 50% of people prescribed CPAP either can't use it often enough to matter or find it too bothersome, according to Harvard Medical School. Common problems include mask discomfort, dry mouth, breathing that feels out of sync and noise from the machine. Late last year, the U.S. Food and Drug Administration approved Zepbound as the first drug to treat people with obesity and sleep apnea. At the time, the sleep medicine society hailed the approval as "a positive development for patients and clinicians, who now have another treatment option for this sleep disorder," according to a statement from the academy. But Zepbound is only for people with obesity and sleep apnea, the society noted. Also, Zepbound can reduce the severity of sleep apnea through weight loss, but might not cure the problem. For the new study, researchers analyzed nationwide online survey data from 365 patients, and also spoke to 17 sleep medicine professionals at UCSD. Doctors favored CPAP over Zepbound 53% to 26%, while patients favored Zepbound over CPAP 48% to 35%. Both doctors and patients supported treatment that combined CPAP and Zepbound, but doctors were more enthusiastic about combination therapy, 88% versus 61%. The patients' preferences are likely driven by their own experiences -- 78% said they were either current or former users of CPAP, results show. By comparison, only 23% of patients said they'd ever used Zepbound or Ozempic (semaglutide), the other prominent GLP-1 drug. Principal investigator Dr. Chris Schmickl, an assistant professor of medicine at University of California-San Diego, expressed surprise at the level of disagreement between patients and providers. "Recognizing differing attitudes toward treatment is crucial for developing a realistic and achievable action plan," he said in a news release. "Additional research to understand the underlying reasons behind these preferences will offer valuable insights for providers to guide treatment decisions." Researchers are scheduled to present these findings Wednesday at the society meeting in Seattle. Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal. More information Harvard Medical School has more on managing CPAP problems. Copyright © 2025 HealthDay. All rights reserved.